X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 22c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.22). Revenue for the quarter came in at $2.57 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Raymond James Reiterates Strong Buy Rating on Marvell (MRVL) following custom silicon/warrant deal with Google
• Lowe's slashes full-year sales outlook amid DIY spending pressure